Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 16-19, 2025 | Boston, MA
November 18-20, 2024Washington, DC
November 19, 2024Washington, DC
January 13-16, 2025San Francisco, CA
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
BIO submitted comments on the recent Rare Disease Endpoint Advancement (RDEA) Pilot Program Workshop, held June 7-8, 2023 (Docket No. FDA-2022-N-2480)
BIO submitted comments on the recent Rare Disease Endpoint Advancement (RDEA) Pilot Program Workshop, held June 7-8, 2023 (Docket No. FDA-2022-N-2480)